Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octohydroaminoacridine Succinate in mild to moderate Alzheimer's Disease
NCT01569516Phase 2Unknown
- Sponsor
- Changchun Huayang High-tech Co., Ltd.
- Start
- Jun 2011
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of octohydroaminoacridine in Alzheimer's disease (AD), sponsored by Changchun Huayang High-tech Co., Ltd.. Status: unknown.
02
Drugs
octohydroaminoacridine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01569516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01569516.